A word of hope for ataxia trials in COVID-19 time and beyond

The coronavirus disease 2019 (COVID-19) crisis confronted us, like many researchers worldwide, with an unforeseen challenge during the final stages of a randomized controlled trial involving ataxia patients. Institutional guidelines suddenly no longer allowed regular follow-up visits to take place,...

Descripción completa

Detalles Bibliográficos
Autores principales: Maas, Roderick P. P. W. M., Ramjith, Jordache, Klockgether, Thomas, Roes, Kit C. B., van de Warrenburg, Bart P. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Short Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508233/
https://www.ncbi.nlm.nih.gov/pubmed/32964331
http://dx.doi.org/10.1007/s00415-020-10231-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508233/
https://www.ncbi.nlm.nih.gov/pubmed/32964331
http://dx.doi.org/10.1007/s00415-020-10231-9

Ejemplares similares